期刊文献+

自身免疫性甲状腺疾病甲状腺细胞Bcl-2、Bax蛋白表达的研究

Expression of Bcl-2 and Bax in thyrocyte of autoimmune thyroid disease
下载PDF
导出
摘要 目的 :探讨Bcl- 2、Bax在自身免疫性甲状腺疾病 (AITD )的表达及意义。方法 :采用免疫组化S -P法检测 54例GD、41例HT及 1 0例正常甲状腺组织作对照 ,用Mias99系统定量分析。结果 :GD、HT的Bcl- 2、Bax表达增高 ,GD的Bcl- 2表达水平高于HT ,Bax表达低于HT(P <0 .0 1 ) ;GD的Bcl- 2阳性颗粒面积及积分光密度与Bax之比高于HT及正常对照 ,HT之比低于正常。结论 :甲状腺Bcl- 2、Bax异常表达 ,尤其是Bcl- 2 /Bax值失衡与AITD的病理过程密切相关。GD的Bcl- 2相对高表达所致的细胞凋亡抑制可能是GD腺体增生、功能亢进的重要因素之一 ;HT的Bax相对高表达所产生的促凋亡效应与HT滤泡破坏。 Objective: To investigate the expression of Bcl-2 and Bax in thyrocyte of autoimmune thyroid disease(AITD) and its significance.Methods: 54 cases of Graves'disease(GD),41 cases of Hashimoto's thyroiditis(HT) and 10 normal thyroid specimens were selected.The expression of Bcl-2 and Bax were detected by immunohistochemical S-P method and analyzed by Mias99 pathological image system. Results: The positive granule area, average light density and total light density of Bcl-2 and Bax in both GD and HT thyrocytes were higher than those in normal thyrocytes( P < 0.01 ). The thyrocytes of GD were strongly immunostained to Bcl-2 while the thyrocytes of HT were strongly immunostained to Bax. The ratios of positive granule area and total light density of Bcl-2 to Bax in GD thyrocyte were higher than that in normal thyroid. On the contrary,those in HT thyrocyte were lower than those in normal thyroid .Conclusion : The abnormal expression of Bcl-2 and Bax thyrocyte, especially the lost of Bcl-2 and Bax equilibrium may contribute to the pathogeneses of AITD. The increased Bcl-2 levels in GD thyrocytes should favor thyrocyte survival, hypertrophy and the enhanced expression of Bax in HT thyrocyte may promote thyrocyte apoptosis and follicle disruption.
出处 《西北国防医学杂志》 CAS 2003年第3期177-179,共3页 Medical Journal of National Defending Forces in Northwest China
关键词 甲状腺疾病 Graves’病 甲状腺炎 自身免疫性 Bcl-2 BAX Thyroid disease Graves'disease Thyroiditis Autoimmune Bcl-2 Bax
  • 相关文献

参考文献7

  • 1Abe Y. Apoptosis in the pathogenesis of autoimmune thyroid disease[J]. Noppon- Rinsho, 1999,57:1717- 1722.
  • 2Kotani T, Aratake Y, Ohtaki S, et al. Apoptosis in Hashimoto's thyroiditis[J]. Rinsho- Byori, 1997,45:1038-47.
  • 3Barnes DM, Dublin EA, Fisher CJ, et al. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indictor of prognosis [J] .Hum Pathol, 1993,24:469- 76.
  • 4Giordano C, Richiusa P, Bagnasco M, et al. Differential regulation of Fas- mediated apoptosis in both thyroctye and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease [ J ].Thyroid, 2001,11 : 233 - 244.
  • 5Hammond LJ, Lowdell MW, Cerrano PG, et al. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto' s autoimmune thyroiditis[J]. J Pathol, 1997, 182:138 - 44.
  • 6Branet F, Caron P, Camallieres M, et al. Bcl- 2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue[J]. Bull Cancer Paris, 1996,83:213-217.
  • 7Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl- 2 are required for inhibition of apoptosis and heterodimerization with Bax[J]. Nature, 1994,369:312 - 313.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部